19:50 EST Praxis Precision Medicines trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PRAX:
- Praxis Precision to showcase pipeline of epilepsy programs at AES meeting
- Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming Meetings
- Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare Conference
- Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies
- Praxis Precision Medicines receives PRIME designation from EMA for PRAX-222